Home

Douglas E. Giordano

CIK 1431552 · last filed 2026-06-22

Douglas E. Giordano is a corporate insider who has filed 8 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for KARD, was dated Jun 22, 2026. Across all open-market trades the lifetime net is +$130.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $372.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$372.6K

Companies

5

Total Filings

8

Lifetime Open-Market Net

$130.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KARD Director 20,706 — — $0 1 2026-06-22
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Director 13,743 $44.96 $617.9K $0 3 2024-06-07
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Director — $18.07 — $0 1 2021-06-14
VTRS Director — $16.22 — $0 1 2020-11-16
ZTS Director 5,000 $74.51 $372.6K $130.0K 1 2013-02-08

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 KARD Grant (A) +20,706 $0 EDGAR
2024-08-05 — Disp (D) −13,743 $0
2024-06-07 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) +10,461 $0 EDGAR
2023-06-09 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) +3,282 $0 EDGAR
2022-06-16 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) — $0 EDGAR
2021-06-14 Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Grant (A) — $0 EDGAR
2020-11-16 VTRS — — $0 EDGAR
2013-02-08 ZTS Buy (P) +5,000 $130.0K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.